drugset / Trial / NCT02659475

Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)

NCT02659475 ↗

NaSingle-groupOpen-labelTreatment

Summary

The goal of this project is to evaluate the effectiveness and tolerability of the novel weight management medication PHEN/TPM ER (Qsymia®)along with nutritional and lifestyle modification counseling in the treatment of binge eating disorder (BED) in overweight or obese individuals.

Timeline

Start
2015-09
Primary completion
2016-07
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject PHEN/TPM ER Unknown — —

Indications